Dominic Labriola Ph.D.
Dominic F. Labriola is Chief Data and Analytics Officer of Madrigal Pharmaceuticals. Dr. Labriola has over 35 years’ experience as a drug developer, overseeing and contributing to the global registration of 20 medicines in multiple therapeutic and more than 20 years serving in executive leadership roles at Bristol Meyers Squibb. His interactions with global regulatory agencies have given him a unique understanding of the drug approval process and the importance of quality data to support those filings. An expert in trial designs and leveraging innovative approaches, he possesses a particular appreciation for the importance of data standards to support clinical research.
Dr. Labriola earned his Ph.D. from the University of Delaware.